S-allylcysteine therapy reduces adverse cardiac remodelling after myocardial infarction in a rat model

S-allylcysteine therapy reduces adverse cardiac remodelling after myocardial infarction in a rat model

Adverse cardiac remodelling such as hypertrophy and fibrosis are strong determinants of heart failure and sudden death after myocardial infarction (MI). This study investigated the impact of S-allylcysteine therapy on adverse cardiac remodelling after MI in a preclinical rat model. Wistar rats (n = ...

Full description

Bibliographic Details
Main Authors: Satirah Zainalabidin, Anand Ramalingam, Siti Fatimah Azaharah Mohamed, Shafreena Shaukat Ali, Jalifah Latip, Wei Boon Yap
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Journal of Functional Foods
Subjects:
Cardiac fibrosis
Glutathione
Hypertrophy
Oxidative stress
S-allylcysteine
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464619306747

Internet

http://www.sciencedirect.com/science/article/pii/S1756464619306747

Similar Items